Cardiology

Dermatology

Endocrinology

Hematology

Lysosomal Disorders 

Neurology

Oncology 

Ophthalmology

Home

News

Media

All Videos

Clinical Trials in Progress

News Network

Partners

CME/CE

Conferences

Subscribe

About Us

Staff

Contact Us

Terms and Conditions

Do Not Sell My Information

Privacy

CGTLive™

Twitter

Facebook

LinkedIn

Topics

Lysosomal Disorders

Oncology

1rem

Continuing Education

Nikhil C. Munshi, MD; Faith E. Davies, MD; Brandon Blue, MD; Shaji Kumar, MD

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma 

PER's Breast Cancer Symposia in San Antonio

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

William G. Wierda, MD, PhD; Jennifer R. Brown, MD, PhD; Ryan Jacobs, MD; Susan M. O’Brien, MD

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

Andre H. Goy, MD; Lorenzo Falchi, MD; Lori A. Leslie, MD; Michael L. Wang, MD

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

Catherine C. Coombs, MD, MS; Lindsey Roeker, MD

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

Loretta J. Nastoupil, MD; Ian W. Flinn, MD, PhD; Caron A. Jacobson, MD, MMSc; Jessica Okosun, MB BChir, PhD 

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

Genovefa Papanicolaou, MD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA; Guenther Koehne, MD, PhD

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

Claire N. Harrison, DM, FRCP, FRCPath; Abdulraheem Yacoub, MD

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

Nikolai A. Podoltsev, MD, PhD; John Mascarenhas, MD

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

Corey Cutler, MD, MPH, FRCPC; Sergio Giralt, MD, FACP, FASTCT; Catherine Lee, MD; Doris M. Ponce, MD

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

Elias Jabbour, MD; Sabina Chiaretti, MD, PhD; Hagop M. Kantarjian, MD; Rob Pieters, MD, PhD; Bijal Shah, MD, MS 

 How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

Pramod K. Mistry, MD, PhD, FRCP, FAASLD; Pavan K. Bendapudi, MD; Nichola Cooper, MD, MA, MBBS, FRCP; Eli Muchtar, MD

"D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective

C. Ola Landgren, MD, PhD; Aaron C. Logan, MD, PhD; Paolo Ghia, MD; Reid W. Merryman, MD

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

Andrew Kuykendall, MD; Marina Kremyanskaya MD, PhD; Lucia Masarova, MD; Douglas A. Tremblay, MD

 How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

Anna Halpern, MD; Jeanne M. Palmer, MD; Bart L. Scott, MD

Oncology Roundtable: Treating MF and PV in 2023

Ajai Chari, MD; Benjamin P. Levy, MD; Daniel P. Petrylak, MD; Diane Reidy-Lagunes, MD; Tiffany A. Traina, MD

 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®  

Naveen Pemmaraju, MD; Monica L. Guzman, PhD; Andrew A. Lane, MD, PhD; Muzaffar H. Qazilbash, MD

 Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

Pramod K. Mistry, MD, PhD, FRCP, FAASLD; Pavan K. Bendapudi, MD; Nichola Cooper, MD, MA, MBBS, FRCP; Eli Muchtar, MD;

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Sikander Ailawadhi, MD; Craig Cole, MD; Anita D'Souza, MD

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

Ajai Chari, MD; Carol Ann Huff, MD; Adriana Rossi, MD

Keeping Pace with Rapid Advancements in Multiple Myeloma Care

David J. Straus, MD; Sharon Castellino, MD, MSc; Joseph M. Connors, MD, CM; Pier Luigi Zinzani, MD, PhD

 Maximizing Our Clinical Practices in Hodgkin Lymphoma: Integration of Recent Data Sets in Real World Settings

ACCC 50th Annual Meeting & Cancer Center Business Summit (AMCCBS): Clinical Updates from San Diego on Hematologic Malignancies

Paolo Ghia, MD; C. Ola Landgren, MD, PhD; Aaron C. Logan, MD, PhD; Reid W. Merryman, MD

 MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

 State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

William G. Wierda, MD, PhD; Jennifer R. Brown, MD, PhD; Ryan Jacobs, MD; Susan M. O'Brien, MD

Community Practice Connections™: Matching the Tumor With Patient-Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

James L.M. Ferrara, MD, DSc; Everett Meyer

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in GvHD Prevention and Treatment

28th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

Toni Choueiri, MD; Shuchi Gulati, MD, MSc; Sumanta Pal, MD, FASCO; Thomas Powles, MBBS, MRCP, MD

Medical Crossfire®: How Does the Evidence Inform Your RCC Sequence? The Experts Share Clinical Perspectives

From Trials to the Real World: Assessing the Role of Allogeneic Transplant and JAK Inhibitors as Treatment Paradigms Evolve in Myelofibrosis

BURST CME™: What Is the Real Risk in Lower-Risk MDS?

BURST CME™: How Does Transfusion Burden Impact Real-World Outcomes in MDS?

BURST CME™: Understanding Transfusion Dependence in Lower-Risk MDS

Expert Illustrations and Commentaries™: Evaluating the Potential for Novel Mechanistic Approaches to Overcome Clinical Gaps in the Care of Patients with LR-MDS

Rishi P. Singh, MD; Peter K. Kaiser, MD; Vaidehi S. Dedania, MD; Jason Hsu, MD

Medical Crossfire®: Expert Perspectives in Geographic Atrophy – How Can We Prepare for a New Era of Treatment?

Clinical Vignettes™: Integrating Novel CAR T-Cell Therapies Across Lymphoid Malignancies with an Eye Toward the Future of Care

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN; Patricia A. Mangan, MSN, CRNP; Edward A. Stadtmauer, MD; 

Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community

Patient, Provider, & Caregiver Connection™

Kara M. Kelly, MD; Julie Comella-Higgins, NP; Sarah Berlinger; Kerry Berlinger

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

Brian Miller, MD, PhD, MPH; Joseph P. McEvoy, MD; Eric Zorn; Jan Zorn

Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment

Irene M. Ghobrial, MD; Surbhi Sidana, MD; Nisha Joseph, MD; Krina Patel, MD, MSc 

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Multiple Myeloma from the Summer Meetings

Grzegorz (Greg) S. Nowakowski MD; Kami J. Maddocks, MD; Ian Flinn, MD; Frederick L. Locke, MD



 Exploring Hot Topics in DLBCL: Sequencing CD19-Targeted Therapies, Strategies Post-CAR T Relapse, Novel Agents, and More!

Do Patients with Multiple Myeloma Still Need Autologous Stem Cell Transplantation?

8th Annual Live Medical Crossfire®: Hematologic Malignancies

Cancer Summaries and Commentaries™: Clinical Updates in MPNs from the Summer Meetings 

William G. Wierda, MD, PhD; Andre H. Goy, MD

  B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

Shaji Kumar, MD; Maria Dimou, MD, PhD; Stephan A. Grupp, MD, PhD; Jose C. Villasboas Bisneto, MD



Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?

Elias Jabbour, MD; Hagop M. Kantarjian, MD

Community Practice Connections™: Multidisciplinary Strategies for Improving Outcomes in CML from Frontline Care… and Beyond!

Beth Faiman PhD, MSN, APRN-BC, AOCN, BMTCN, FAAN, FAPO; Laura Zitella, MS, RN, ACNP-BC, AOCN

Crucial Conversations in R/R Multiple Myeloma: Nursing Strategies to Optimize Patient Communication and Improve Outcomes

Community Practice Connections™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in AML

Saad Usmani, MD, MBA, FACP; Joseph R. Mikhael, MD, MEd, FRCPC, FACP

Oncology Briefings™: Coordinating the Long-Term Management of Patients With Multiple Myeloma Between Primary Care and Oncology Practices

GlobaOncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of B-Cell Lymphomas with BTK Inhibitors

Grace Cherry, MSN, RN, NP; Laura S. Wood, MSN, RN, OCN; Beth Sandy, MSN, CRNP, OCN; Amy Goodrich, MSN, RN, CRNP-AC 

Community Practice Connections: 7th Annual School of Nursing Oncology™

Ajai Chari, MD; Alfred Chung, MD; Adriana Rossi, MD

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

Community Oncology Connections™: Overcoming Clinical Challenges and Embracing New Opportunities in the Management of Multiple Myeloma

Catherine M. Broome, MD; Ilene Ceil Weitz, MD; David Kuter, MD, DPhil

Improving Outcomes in Autoimmune Hemolytic Anemias at the Intersection Between Hematology and Oncology Care

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for Emerging E-Selectin Antagonists in the Management of AML

Myeloma Management Considerations: Applying the Evidence With Monoclonal Antibody Based Regimens

Ilene Ceil Weitz, MD; Bhumika J Patel, MD

Upcoming CME Events & Activities

EVENTS

ACTIVITIES